{"entity":{"type":"insider","cik":"0001788524","url":"/insider/0001788524","json_url":"/insider/0001788524.json","name":"Thompson Rahsaan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2025-06-30","last":"2026-08-17","span_basis":"filed_date"},"name_variants":[{"name":"Thompson Rahsaan","source":"filing","n_filings":5,"first_seen":"2025-06-30","last_seen":"2026-08-17"}],"transactions":[{"id":9287722,"accession":"0001434647-26-000073","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001434647-26-000073","line_url":"/filing/0001434647-26-000073#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001788524","owner_name":"Thompson Rahsaan","owner_display_name":"Thompson Rahsaan","owner_url":"/insider/0001788524","role":"Officer (Chief Legal & Compliance)","role_mark":"O","role_mark_label":"Officer (Chief Legal & Compliance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal & Compliance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42666.0,"shares_display":"42,666","price_per_share":11.1277,"price_display":"11.13","price_state":"stated","total_value":474774.4482,"total_display":"474,774.45","total_whole":"474,774","shares_owned_after":37569.0,"shares_owned_after_display":"37,569","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-14","filed_date":"2026-08-17","scope":"insider"},{"id":6091834,"accession":"0001434647-26-000057","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001434647-26-000057","line_url":"/filing/0001434647-26-000057#line-2","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001788524","owner_name":"Thompson Rahsaan","owner_display_name":"Thompson Rahsaan","owner_url":"/insider/0001788524","role":"Officer (Chief Legal & Compliance)","role_mark":"O","role_mark_label":"Officer (Chief Legal & Compliance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal & Compliance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34557.0,"shares_display":"34,557","price_per_share":12.6835,"price_display":"12.68","price_state":"stated","total_value":438303.7095,"total_display":"438,303.71","total_whole":"438,304","shares_owned_after":80235.0,"shares_owned_after_display":"80,235","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-22","filed_date":"2026-06-23","scope":"insider"},{"id":6053174,"accession":"0001434647-26-000034","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001434647-26-000034","line_url":"/filing/0001434647-26-000034#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001788524","owner_name":"Thompson Rahsaan","owner_display_name":"Thompson Rahsaan","owner_url":"/insider/0001788524","role":"Officer (Chief Legal & Compliance)","role_mark":"O","role_mark_label":"Officer (Chief Legal & Compliance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal & Compliance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1794.0,"shares_display":"1,794","price_per_share":11.3,"price_display":"11.30","price_state":"stated","total_value":20272.2,"total_display":"20,272.20","total_whole":"20,272","shares_owned_after":48125.0,"shares_owned_after_display":"48,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-11","filed_date":"2026-05-13","scope":"insider"},{"id":5876543,"accession":"0001788524-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001788524-26-000002","line_url":"/filing/0001788524-26-000002#line-2","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001788524","owner_name":"Thompson Rahsaan","owner_display_name":"Thompson Rahsaan","owner_url":"/insider/0001788524","role":"Officer (Chief Legal & Compliance), Other","role_mark":"O","role_mark_label":"Officer (Chief Legal & Compliance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal & Compliance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4080.0,"shares_display":"4,080","price_per_share":8.8259,"price_display":"8.83","price_state":"stated","total_value":36009.672,"total_display":"36,009.67","total_whole":"36,010","shares_owned_after":49919.0,"shares_owned_after_display":"49,919","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-30","filed_date":"2026-02-02","scope":"insider"},{"id":4921593,"accession":"0001437749-25-021577","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-25-021577","line_url":"/filing/0001437749-25-021577#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001788524","owner_name":"Thompson Rahsaan","owner_display_name":"Thompson Rahsaan","owner_url":"/insider/0001788524","role":"Officer (Chief Legal & Compliance), Other","role_mark":"O","role_mark_label":"Officer (Chief Legal & Compliance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal & Compliance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24000.0,"shares_display":"24,000","price_per_share":9.2085,"price_display":"9.21","price_state":"stated","total_value":221004.0,"total_display":"221,004.00","total_whole":"221,004","shares_owned_after":42666.0,"shares_owned_after_display":"42,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-26","filed_date":"2025-06-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001434647","name":"ZEVRA THERAPEUTICS, INC.","url":"/issuer/0001434647","role":"Officer (Chief Legal & Compliance), Other","n_filings":5,"first_seen":"2025-06-30","last_seen":"2026-08-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001788524","retrieved_at":"2026-08-27T06:19:51+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}